Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statement

Vertex Pharmaceuticals Executive Vice President Jasper van Grunsven filed an initial Form 3 insider ownership statement on September 8, 2026. The disclosure was published via EDGAR on September 10, 2026.

Vertex Pharmaceuticals EVP Jasper van Grunsven filed an initial Form 3 insider ownership statement dated Sept. 8, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vertex Pharmaceuticals Incorporated published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000875320-26-000270), on September 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here